Discover and read the best of Twitter Threads about #CNCP
Most recents (2)
Recently, @Peter_Grinspoon of Harvard / MGH provided a lecture to physicians, researchers & Oz public touching on:
“The Top 5 Ways in Which Cannabinoids Supplement Opiates in #CNCP Patients”
A🧵:
CC:
@RACGP @ANZCA_FPM @TGAgovau @ChooseWiselyAU (your advices out of date)
“The Top 5 Ways in Which Cannabinoids Supplement Opiates in #CNCP Patients”
A🧵:
CC:
@RACGP @ANZCA_FPM @TGAgovau @ChooseWiselyAU (your advices out of date)
Before the big 5 he qualifies comments:
a) threshold question- Is Cannabis less harmful or risky than alternative ?
b) is it safer in the particular indication?
c) communications between doctor & patient key
d) real world evidence (Eg insurance claims data) - v important
a) threshold question- Is Cannabis less harmful or risky than alternative ?
b) is it safer in the particular indication?
c) communications between doctor & patient key
d) real world evidence (Eg insurance claims data) - v important
e) community becoming more rotund and arthritic- answer to this ≠ opiates; cannabinoids even cbd more readily indicated in inflammatory conditions
f) cannabinoids can be good for patients (HRQoL, sleep & pain) & helps doctors save time, help more folks via less appointments
f) cannabinoids can be good for patients (HRQoL, sleep & pain) & helps doctors save time, help more folks via less appointments
Not sure where to start the discussion on this article. I am very interested in multiple aspects of this paper. First, & this is just related to this paper but the overall current climate of the treatment & care of those with #Chronicpain
#HHS #Chou 1/ nam.edu/best-practices…
#HHS #Chou 1/ nam.edu/best-practices…
So much energy has gone into research looking to define optimal strategies for opioid tapering where is the energy being given to development of other medications that are as effective as opioids with less risk? I know this paper referenced that many #patients tapered 2/
